Outlook Therapeutics Inc Stock Analysis

OTLK Stock  USD 2.24  0.18  8.74%   
OUTLOOK THERAPEUTICS INC is undervalued with Real Value of 7.86 and Hype Value of 2.21. The main objective of OUTLOOK THERAPEUTICS stock analysis is to determine its intrinsic value, which is an estimate of what OUTLOOK THERAPEUTICS INC is worth, separate from its market price. There are two main types of OUTLOOK THERAPEUTICS's stock analysis: fundamental analysis and technical analysis.
The OUTLOOK THERAPEUTICS stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

OUTLOOK Stock Analysis Notes

About 36.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 4.41. OUTLOOK THERAPEUTICS INC last dividend was issued on the 18th of March 2019. The entity had 1:20 split on the 14th of March 2024. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Outlook Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people. To find out more about OUTLOOK THERAPEUTICS INC contact Russell III at 609 619 3990 or learn more at https://www.outlooktherapeutics.com.

OUTLOOK THERAPEUTICS INC Investment Alerts

OUTLOOK THERAPEUTICS generated a negative expected return over the last 90 days
OUTLOOK THERAPEUTICS has high historical volatility and very poor performance
OUTLOOK THERAPEUTICS has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 5.85 M. Net Loss for the year was (75.37 T) with loss before overhead, payroll, taxes, and interest of (42.33 M).
OUTLOOK THERAPEUTICS INC currently holds about 26.02 M in cash with (68.79 T) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12.
OUTLOOK THERAPEUTICS has a frail financial position based on the latest SEC disclosures
Roughly 36.0% of the company outstanding shares are owned by corporate insiders

OUTLOOK THERAPEUTICS INC Upcoming and Recent Events

13th of February 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of December 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

OUTLOOK Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 55.79 M.

Technical Drivers

As of the 4th of January, OUTLOOK THERAPEUTICS holds the Coefficient Of Variation of (2,021), risk adjusted performance of (0.03), and Market Risk Adjusted Performance of 0.9761. In connection with fundamental indicators, the technical analysis model allows you to check available technical drivers of OUTLOOK THERAPEUTICS, as well as the relationship between them.

OUTLOOK THERAPEUTICS INC Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. OUTLOOK THERAPEUTICS middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for OUTLOOK THERAPEUTICS INC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

OUTLOOK THERAPEUTICS INC Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific OUTLOOK THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on OUTLOOK THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases OUTLOOK THERAPEUTICS insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Gangolli Julian S over a month ago
Acquisition by Gangolli Julian S of 71169 shares of OUTLOOK THERAPEUTICS at 5.22 subject to Rule 16b-3
 
Auffarth Gerd over two months ago
Acquisition by Auffarth Gerd of 56636 shares of OUTLOOK THERAPEUTICS at 5.22 subject to Rule 16b-3
 
Thurman Randy H over two months ago
Acquisition by Thurman Randy H of 89549 shares of OUTLOOK THERAPEUTICS at 5.22 subject to Rule 16b-3
 
Thurman Randy H over three months ago
Acquisition by Thurman Randy H of 56636 shares of OUTLOOK THERAPEUTICS at 5.22 subject to Rule 16b-3
 
Kenyon Lawrence A over three months ago
Acquisition by Kenyon Lawrence A of 5000 shares of OUTLOOK THERAPEUTICS at 5.6892 subject to Rule 16b-3
 
Huang Andong over three months ago
Acquisition by Huang Andong of 41065 shares of OUTLOOK THERAPEUTICS at 1.05 subject to Rule 16b-3
 
Sukhtian Faisal Ghiath over six months ago
Acquisition by Sukhtian Faisal Ghiath of 94441 shares of OUTLOOK THERAPEUTICS at 0.41 subject to Rule 16b-3
 
Evanson Jeff over six months ago
Acquisition by Evanson Jeff of 800000 shares of OUTLOOK THERAPEUTICS at 1.44 subject to Rule 16b-3
 
Haller Julia A over six months ago
Acquisition by Haller Julia A of 94441 shares of OUTLOOK THERAPEUTICS at 0.41 subject to Rule 16b-3
 
Lawrence Kenyon over six months ago
Acquisition by Lawrence Kenyon of 12500 shares of OUTLOOK THERAPEUTICS at 6.78 subject to Rule 16b-3
 
Haller Julia A over six months ago
Acquisition by Haller Julia A of 94441 shares of OUTLOOK THERAPEUTICS at 0.41 subject to Rule 16b-3
 
Thurman Randy H over six months ago
Acquisition by Thurman Randy H of 94441 shares of OUTLOOK THERAPEUTICS at 0.41 subject to Rule 16b-3

OUTLOOK THERAPEUTICS Outstanding Bonds

OUTLOOK THERAPEUTICS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. OUTLOOK THERAPEUTICS INC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most OUTLOOK bonds can be classified according to their maturity, which is the date when OUTLOOK THERAPEUTICS INC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

OUTLOOK THERAPEUTICS Predictive Daily Indicators

OUTLOOK THERAPEUTICS intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of OUTLOOK THERAPEUTICS stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

OUTLOOK THERAPEUTICS Forecast Models

OUTLOOK THERAPEUTICS's time-series forecasting models are one of many OUTLOOK THERAPEUTICS's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary OUTLOOK THERAPEUTICS's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About OUTLOOK Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how OUTLOOK THERAPEUTICS prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling OUTLOOK shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as OUTLOOK THERAPEUTICS. By using and applying OUTLOOK Stock analysis, traders can create a robust methodology for identifying OUTLOOK entry and exit points for their positions.
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Outlook Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding OUTLOOK THERAPEUTICS to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Rebalancing Now

   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module
When determining whether OUTLOOK THERAPEUTICS INC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if OUTLOOK Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Outlook Therapeutics Inc Stock. Highlighted below are key reports to facilitate an investment decision about Outlook Therapeutics Inc Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OUTLOOK THERAPEUTICS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.